Amsbio has launched Solu BL21 Competent E Coli, an improved BL21 host strain for soluble mammalian protein expression.
Using a directed evolution approach, a mutant strain of BL21(DE3) E Coli has been developed that can produce soluble protein in the majority of cases where expression in the parent BL21(DE3) yielded no detectable soluble product.
This improvement should enable scientists to make progress in a range of applications quicker and less expensively than in the past.
Use of the Solu BL21 Competent E Coli follows a simple and straightforward protocol, the product is compatible with all T7 promoter-based expression vectors.
